http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0188180-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_648d894b46961773ad412a6c3b0666e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_328417a5dc42c41ad4ce87e12cbce1ba |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-02 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-191 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19 |
| filingDate | 2001-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37fd5ce02ca897beba0d1cc9a11dc5dd |
| publicationDate | 2001-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-0188180-A2 |
| titleOfInvention | Tnf and ifn stimulated genes and uses therefor |
| abstract | The present invention is directed to the identification of genes that are expressed at a higher level in certain TNF and IFN treated cells than in otherwise identical untreated cells. Genes that are expressed at a higher level in TNF and IFN treated cells than untreated cells ('TNF and IFN stimulated genes') are of interest, in part, because TNF and IFN can or could influence a wide range of cellular processes and responses for antiviral activity. The identified TNF and IFN stimulated genes and the proteins they encode can be used: 1) as therapeutic agents which modulate a cellular process or response that is influenced by TNF and IFN; 2) as targets for use in high throughput screening and the development of therapeutic agents which modulate a cellular process or response that is influenced by TNF and IFN; and 3) as markers which can be used to detect and monitor a cellular process or response that is influenced by TNF and IFN. |
| priorityDate | 2000-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1777.